temoporfin has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balusikova, K; Bartunek, P; Kahle, M; Kolar, M; Kralova, J; Lettlova, S; Truksa, J | 1 |
| Bezdetnaya, L; D'Hallewin, MA; Dumas, D; Gräfe, S; Guillemin, F; Lassalle, HP | 1 |
2 other study(ies) available for temoporfin and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Neoplasm; Ethylene Glycols; Female; Gene Knockdown Techniques; Glycols; Humans; Mammary Neoplasms, Animal; MCF-7 Cells; Mesoporphyrins; Mice; Paclitaxel; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2017 |
Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Female; Liposomes; Mammary Neoplasms, Animal; Mesoporphyrins; Mice; Mice, Nude; Neoplasms, Experimental; Phosphatidylglycerols; Photochemotherapy; Photosensitizing Agents | 2009 |